StemCells (STEM) PT Cut to $3 at Maxim Group
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
Go back to StemCells (STEM) PT Cut to $3 at Maxim Group
December 23, 2015 8:10 AM EST
(Updated - December 23, 2015 8:16 AM EST)
StemCells (NASDAQ: STEM) Declines After Shares Resume Trading
...
More
December 23, 2015 8:07 AM EST
StemCells, Inc. (NASDAQ: STEM) today announced a strategic realignment to fully focus the Companys resources on its proprietary HuCNS-SC® platform technology for the treatment of chronic spinal cord injury (SCI).
Evidence of efficacy from the Companys ongoing clinical trials in chronic SCI offers therapeutic promise to restore lost function previously considered unrecoverable. StemCells recently reported a pattern of improvements in both strength and motor function, six months post-transplant of its proprietary HuCNS-SC cells, in the first cohort of its Phase II Pathway Study in cervical spinal cord injury. These interim... More
December 23, 2015 8:01 AM EST
StemCells (NASDAQ: STEM) Halted, News Pending
...
More
